SUMMARY The accuracy of diagnosis in 656 patients with the four common histopathological types of primary lung cancer has been assessed by comparing the cell type diagnosis made on cytological and histological investigation with that determined by examination of the surgically resected or necropsy specimen. The accuracy of diagnosis achieved by cytological examination of sputum and bronchial aspirate, and by bronchial biopsy histology was over 85%. The least accurate diagnostic procedure was percutaneous needle biopsy (62%). Squamous and small cell tumours were accurately diagnosed by all four investigations but errors were made in the diagnosis of large cell and adenocarcinomas. Nearly half the number of patients (43%) with large cell carcinoma were later reclassified as having squamous carcinoma and of the patients with adenocarcinoma 32% had been predicted to be squamous and 18% large cell carcinoma. We consider such quality control of pretreatment diagnosis mandatory in management of individual patients and before enrolment in clinical trials.
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In 1979 a study was reported from Papworth Hospital, Cambridge which examined the accuracy of diagnosis of cell type in patients with primary lung cancer.' The presumptive cell type as predicted by cytology and biopsy techniques was compared with the true histological cell type as determined by histological examination of tumour tissue obtained at surgical resection or necropsy. The results indicated that the true cell type was most accurately predicted by sputum cytology (88 Y.), closely followed by bronchial aspiration (84%) and bronchial biopsy (80 %). The least accurate procedure was percutaneous needle biopsy (48 %). Diagnostic accuracy was highest in patients with squamous cell carcinoma while particular difficulty was experienced in diagnosis of patients with adenocarcinoma.
Inevitably, with such a study limited to a four-year period in a single hospital, the number of patients in each histological group was relatively small. We have therefore undertaken a larger study of 673 patients with confirmed lung cancer seen at two centres, Papworth Hospital, Cambridge and Brompton Hospital, London and this includes the results of the original work from Papworth.
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Material and methods
We have reviewed the results of cytological and histological investigation in a series of consecutive patients with primary lung cancer seen at Papworth and Brompton Hospitals in the years [1974] [1975] [1976] [1977] [1978] [1979] inclusive and who had surgical resection or necropsy examination. Tissue for final diagnosis was obtained by thoracotomy in 603 patients and at necropsy in 69 patients, the "true histological cell type" being taken to be that of the resected or necropsy specimen. The "presumptive histological cell type" was that reported in the four investigative methods studied; cytological examination of sputum and bronchial aspirate, histological examination of bronchial biopsy, and cytology of percutaneous needle aspiration biopsy. All patients had one or more of these investigations.
CYTOLOGY OF SPUTUM AND BRONCHIAL ASPIRATE
The number of sputum samples obtained from each patient ranged from one to eight and cytology results were included in the study only if the sputum specimen contained alveolar macrophages as an indication of pulmonary origin. 415 (62 %), small cell carcinoma in 49 (7 %), adenocarcinoma in 145 (22%), and large cell undifferentiated in 47 (7 %). In addition, seven patients (1 %) had a true mixed adenosquamous carcinoma, eight (1 %) had bronchioloalveolar carcinoma and two (03%) had alveolar cell carcinoma but these have been excluded from the study as explained above. Of 656 patients analysed, 387 (59%) had cytological examination of sputum, 342 (52%) cytological examination of bronchial aspirate, 379 (58%) histological examination of bronchial biopsy and 82 (13%) cytological examination of percutaneous needle biopsy specimens.
We examined the results from both centres separately and found them to be in general agreement and therefore we feel justified in combining the results in this study to obtain the benefit of greater numbers.
DIAGNOSTIC YIELD OF EACH METHOD OF INVESTIGATION
It was not the main purpose of this study to examine the yield from these investigations since not all patients had all four investigations. However, comparisons of different techniques must be based on both yield and accuracy and the yield of each investigation is, therefore, presented in Table 1 Squamous  116  111  96  103  96  93  199  193  97  37  29  78  Small cell  12  11  92  10  7   70  22  21  95  2  2  100   Adenocarcinoma  25  16  64  10  3  30  24  14  58  21  7  33   Large cell   8  5  63  3  2  67  9  5  56  6  3  50 were correctly diagnosed. Both patients who had percutaneous biopsy for peripheral small cell tumours were correctly predicted but only seven of 10 bronchial aspirate results were correct, the predicted cell type being adenocarcinoma in two and squamous carcinoma in one.
Patients with adenocarcinoma The accuracy of diagnosis of patients with adenocarcinoma was poor. Only 64% examined by sputum cytology, 30% by bronchial aspirate, 58% by bronchial biopsy and 33 % by percutaneous needle biopsy were correctly diagnosed. The incorrect presumptive diagnosis in two thirds of these patients was squamous carcinoma and in one third, large cell carcinoma.
Patients with large cell undifferentiated carcinoma Accurate diagnosis of patients with large cell carcinoma varied from 50% to 67% but the number of positive results in this group was small. Nine out of 11 patients incorrectly diagnosed were thought to have poorly differentiated squamous cell carcinomas, the other two being thought to have adenocarcinoma.
Discussion
It is important to know accurately the true histopathological cell type in cases of primary lung cancer and to know the accuracy of diagnosis achieved by the cytological and histological procedures. In the individual patient it will influence decisions on operability,6 and other types of treatment7-9 and will allow prediction of prognosis.6 [10] [11] [12] In addition it is a prime consideration in many therapeutic trials in lung cancer and as such will govern the entry of the individual patient into such trials.
To obtain a sufficient number of patients for analysis we have looked at the results of investigation at two different centres. However, there are inherent problems in such a study. Observer variability in the histopathological diagnosis of lung cancer is well recognised, especially in the interpretation of poorly differentiated carcinomas '3 14 and this may assume importance with the involvement of different pathologists in two centres, although in our case we have found no major differences of terminology between Papworth and Brompton. The policy at Brompton Hospital of not examining bronchial aspirate material in some patients with a positive diagnosis of carcinoma on bronchial biopsy will have reduced the yield of malignancy by bronchial aspiration but accuracy of diagnosis of cell type should not have been affected.
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The frequency of individual cell types in our patients reflects their selection on the basis of surgical resection (90%) and necropsy examination (10%). The distribution is similar to that of other reported series of surgical cases '6 16 In any classification there has to be a group in which to place cases that cannot be classified into any of the other better-defined groups. In the context of this paper the undifferentiated large cell group is this residual group. It is not surprising therefore that a higher proportion of diagnoses based on small samples are reclassified when larger amounts of tissue are available for examination and occasional areas of squamous or adenocarcinomatous differentiation are seen.
The difficulty in accurate cell typing resulting from the small size of sample in biopsy and cytology specimens is reflected in the underdiagnosis of adenocarcinomas. The diagnostic features of tubules, mucin vacuoles, terminal plates, solid three-dimensional cell clumps, typical nuclei with prominent nucleoli, may well not be present or they may be masked by cell overlap in the limited sample available. One of the outcomes of the earlier paper' has been a re-examination of the criteria for diagnosing adenocarcinoma with special attention to tubule formation, terminal plates, and mucin vacuoles.
We consider it mandatory that centres involved in the diagnosis and treatment of bronchial carcinoma should undertake this type of quality control since it not only helps in the management of individual patients but also aids the interpretation of clinical trials of treatment regimens. 
